肝脏杂志

抽象的

Market Analysis of 23rd World Congress on Toxicology and Pharmacology | Webinar

Marzieh Daniali

Drug manufacturers are incorporating ADME toxicity testing in early phases of drug development to meet the increasing demand to control drug toxicities which is expected to drive growth of this market. Introduction of technologically advanced computer based testing models are further improving growth of this market. ADME toxicity testing market is studied in reference to in-vitro and in-vivo technologies. In-Owing to increasing ethical concerns over animal use in clinical trials, in-vivo toxicity testing methods are gaining popularity. Use of ADME toxicity computer modelling is expected to rise due to its capability of effective cost reduction, due to early ADME toxicity prediction and other associated benefits related to increase throughput screening